BioSpace News Archive

Aquestive Therapeutics, Inc. (NASDAQ:AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address patients’ unmet needs and solve therapeutic problems, today reported audited financial results for the fourth quarter and full year ended December 31, 2019 and provided an update on recent developments in its business.

PTC Therapeutics, Inc. announced that on March 6, 2020 it approved non-statutory stock options to purchase an aggregate of 103,750 shares of its common stock to 35 new employees.

InVivo Therapeutics Holdings Corp. announced the closing of its previously announced public offering of 2,545,455 shares of common stock, together with warrants to purchase up to 2,545,455 shares of common stock at a combined effective price to the public of $2.75 per share and associated warrant.

Adverum Biotechnologies, Inc. announced presentations on the company’s gene therapy programs to be presented at the Association for Vision and Ophthalmology 2020 Congress in Baltimore, MD.

Engage Therapeutics, Inc. announced that its Phase 2b StATES study of Staccato® alprazolam met its primary endpoint which was proportion of responders achieving cessation of seizure activity within two minutes of treatment administration and no recurrence within two hours.

Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that Melissa Layman has been named Chief Commercial Officer (CCO).

As bottles of soap are flying off the shelves and hand sanitizer is in short supply since the global spread of Novel Coronavirus COVID-19, people are paying more attention to hand washing practices.

BioLife Solutions, Inc. (NASDAQ: BLFS) (“BioLife” or the “Company”), a leading developer and supplier of a portfolio of best-in-class bioproduction tools for cell and gene therapies, today reported financial results and operational highlights for the fourth quarter and full year ended December 31, 2019.

Baxter International Inc., a leading global medical products company, will host a conference call to discuss its fourth-quarter 2019 financial results on Tuesday, March 17, 2020, at 7:30 a.m. Central Time.

CRH Medical Corporation, announced financial and operating results for the year and three months ended December 31, 2019.